Finance

Roʻyxatlar
Istiqbol: 25.9% optimistik·29.6% pessimistik
Tahlilga kirish
BSX:NYSE
Boston Scientific Corp
43,31 US$
-1,23%
(-0,54) 1K
43,60 US$
+0,67% (+0,29)
Yopilgandan keyin
Savdolar yopilgan: 13-okt, 16:00:05 (GMT-4)  ·   USD
Barcha belgilar
BelgiNarxiOʻzgartirishlarDinamika (%)
BSX tikeri uchun statistika yaratilmoqda...
Ochish
43,95 US$
Yuqori
44,15 US$
Past
42,46 US$
Bozor kapitali
62,77 mlrd
Oʻrtacha hajm
19,54 mln
Hajmi
14,27 mln
P/E koeffitsiyenti
17,56
52 haftalik eng yuqori
105,65 US$
52 haftalik eng past
41,38 US$
Aksiya boʻyicha daromad
2,47 US$
Beta
0,58
Muomaladagi aksiyalar
1,45 mlrd
Xodimlar soni
59 ming
Ochish
43,95 US$
Yuqori
44,15 US$
Past
42,46 US$
Bozor kapitali
62,77 mlrd
Oʻrtacha hajm
19,54 mln
Hajmi
14,27 mln
P/E koeffitsiyenti
17,56
52 haftalik eng yuqori
105,65 US$
52 haftalik eng past
41,38 US$
Aksiya boʻyicha daromad
2,47 US$
Beta
0,58
Muomaladagi aksiyalar
1,45 mlrd
Xodimlar soni
59 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Profil
Boston Scientific Corporation is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology. The company is known for developing the Taxus Stent, a drug-eluting stent that is used to open clogged arteries. BSC is headquartered in Marlborough, Massachusetts and incorporated in Delaware. Wikipedia
Boston Scientific Corp haqida
CEOMichael F. Mahoney
Xodimlar soni59 ming
Asos solingan29-iyn, 1979
Bosh ofislarMarlborough, Massachusetts, Amerika Qo‘shma Shtatlari
Sektor-
Analitik reytinglar
Oxirgi 3 oyda BSX aksiyalari boʻyicha reyting bergan 23 tahlilchi xulosasiga koʻra
Sotib olish tavsiya etiladi
Sotib olish
19
Ushlab qolish
4
Sotish
0
12 oylik prognoz
Oxirgi 3 oyda BSX uchun 12 oylik narx maqsadlarini taklif qilgan 23 Wall Street tahlilchisi xulosasiga koʻra
Eng yuqori
Joriy 43,31 US$
70,00 US$ (+61,63%)
O‘rtacha
57,29 US$ (+32,28%)
Eng past
48,00 US$ (+10,83%)
Analitik
Tavsiya
Amal
Kutilayotgan narx
Prognoz
Sana
Anthony Petrone
Mizuho Securities
Buy
Reiterated
55,00 US$
+27%
10/13/2026
Marie Thibault
BTIG
Buy
Reiterated
56,00 US$
+29,3%
10/12/2026
Mike Kratky
Leerink Partners
Buy
Reiterated
55,00 US$
+27%
10/12/2026
Christopher Pasquale
Barclays
Hold
Initiated
48,00 US$
+10,8%
10/07/2026
Matt Miksic
Barclays
Hold
Maintained
48,00 US$
+10,8%
10/07/2026
Joanne Wuensch
Citi
Hold
Reiterated
48,00 US$
+10,8%
10/05/2026
Unknown Analyst
Bernstein
Buy
Reiterated
54,00 US$
+24,7%
10/02/2026
Robbie Marcus
J.P. Morgan
Buy
Maintained
56,00 US$
+29,3%
10/01/2026
Kendall Au
RBC Capital
Buy
Maintained
70,00 US$
+61,6%
10/01/2026
Larry Biegelsen
Wells Fargo
Hold
Reiterated
48,00 US$
+10,8%
09/24/2026
Suraj Kalia
Oppenheimer
Buy
Reiterated
65,00 US$
+50,1%
09/21/2026
Travis Steed
Bank of America Securities
Buy
Maintained
54,00 US$
+24,7%
09/20/2026
Josh Jennings
TD Cowen
Buy
Maintained
56,00 US$
+29,3%
09/17/2026
Matthew Taylor
Jefferies
Buy
Maintained
60,00 US$
+38,5%
09/11/2026
Richard Newitter
Truist Financial
Buy
Maintained
-
-
09/09/2026
David Toung
Argus Research
Hold
Downgraded
-
-
07/30/2026
Vijay Kumar
Evercore ISI
Buy
Maintained
55,00 US$
+27%
07/30/2026
Pito Chickering
Deutsche Bank
Buy
Maintained
60,00 US$
+38,5%
07/30/2026
David Rescott
Robert W. Baird
Buy
Maintained
56,00 US$
+29,3%
07/30/2026
William Plovanic
Canaccord Genuity
Buy
Reiterated
66,00 US$
+52,4%
07/30/2026
Shagun Singh Chadha
RBC Capital
Buy
Reiterated
70,00 US$
+61,6%
07/29/2026
Michael Matson
Needham
Buy
Maintained
57,00 US$
+31,6%
07/29/2026
Patrick Wood
UBS
Buy
Maintained
67,00 US$
+54,7%
07/30/2026
Rick Wise
Stifel Nicolaus
Buy
Maintained
60,00 US$
+38,5%
07/29/2026
Unknown Analyst
Oppenheimer
Buy
Maintained
85,00 US$
+96,3%
07/27/2026
David Roman
Goldman Sachs
Buy
Maintained
57,00 US$
+31,6%
07/14/2026
Matthew O'Brien
Piper Sandler
Buy
Maintained
65,00 US$
+50,1%
06/12/2026
Stephanie Elghazi
Bank of America Securities
Buy
Maintained
68,00 US$
+57%
06/09/2026
Michael Polark
Wolfe Research
Hold
Downgraded
-
-
05/29/2026
Hans Engel
Erste Group
Hold
Reiterated
-
-
04/01/2026
Jayson Bedford
Raymond James
Buy
Maintained
88,00 US$
+103,2%
03/27/2026
Danielle Antalffy
UBS
Buy
Reiterated
105,00 US$
+142,4%
03/17/2026
Lee Hambright
Bernstein
Buy
Maintained
112,00 US$
+158,6%
02/05/2026
Oxirgi hisobot
29-iyl, 2026
Moliya davri
Ch.2 2026
0,86 US$ / 0,83 US$
+3,86%musbat
Taxminiy daromad (USD)
5,44 mlrd / 5,37 mlrd
+1,42%musbat
Q2 2026 uchun tushumlar hisoboti
Tushumlar hisoboti kutilmoqda
Qisqacha
Oxirgi yangiliklar va hisobotlar sarhisobi
Avvalgi hisobotlarBarcha qiymatlar – USD
Loading Previous Earnings...
Daromad
Sof foyda
Barcha qiymatlar – USD
sen, 2025
dek, 2025
mar, 2026
iyn, 2026
Daromad
5,06 mlrd
5,29 mlrd
5,20 mlrd
5,44 mlrd
Sotilgan mahsulotning tannarxi
1,54 mlrd
1,61 mlrd
1,60 mlrd
1,61 mlrd
Daromad narxi
1,54 mlrd
1,61 mlrd
1,60 mlrd
1,61 mlrd
Tadqiqot va ishlanmalarga xarajatlar
514,00 mln
569,00 mln
516,00 mln
554,00 mln
Tadqiqot va ishlanmalarga xarajatlar jami xarajatlar
-
-
-
-
Tijoriy, umumiy va maʼmuriy xarajatlar
1,74 mlrd
1,83 mlrd
1,78 mlrd
1,80 mlrd
Operatsion xarajatlar
2,48 mlrd
2,63 mlrd
2,53 mlrd
2,59 mlrd
Jami operatsion xarajatlar
4,02 mlrd
4,24 mlrd
4,13 mlrd
4,20 mlrd
Operatsion daromad
1,05 mlrd
1,04 mlrd
1,07 mlrd
1,25 mlrd
Boshqa nooperatsion daromad
-16,00 mln
28,00 mln
28,00 mln
-6,00 mln
Soliq toʻlangunga qadar foyda, shu jumladan gʻayrioddiy moddalar
938,00 mln
700,00 mln
1,16 mlrd
1,06 mlrd
Soliq toʻlangunga qadar foyda, gʻayrioddiy moddalar bundan mustasno
935,00 mln
1,01 mlrd
999,00 mln
1,14 mlrd
Daromad soligʻi boʻyicha xarajat
183,00 mln
30,00 mln
-176,00 mln
155,00 mln
Amaldagi soliq stavkasi
19,51%
4,29%
-15,13%
14,62%
Boshqa operatsion xarajatlar
-
-
-
-
Sof foyda
755,00 mln
672,00 mln
1,34 mlrd
907,00 mln
Sof foyda marjasi
14,91%
12,71%
25,77%
16,67%
Har bir aksiya foydasi
0,75
0,80
0,80
0,86
Foizlar va investitsiyalardan olingan daromadlar
-
29,00 mln
-
11,00 mln
Foizlarni toʻlash xarajatlari
-87,00 mln
-90,00 mln
-90,00 mln
-96,00 mln
Foizlarni toʻlash boʻyicha sof xarajatlar
-87,00 mln
-61,00 mln
-90,00 mln
-85,00 mln
Amortizatsiya ajratmalari
-
-
-
-
EBITDA
1,39 mlrd
1,41 mlrd
1,42 mlrd
1,60 mlrd
Aktivlarni sotishdan olingan foyda yoki zarar
-
-
-
-
Insayder tranzaksiyalari
Insayder tranzaksiyalari maʼlumotlari tashqi manbalardan olingan. Batafsil
Insayder
Joylashuvi
Turi
Sana
Aksiyalar
Miqdor
1-sahifa
AI kontentda xatolar boʻlishi mumkin. Batafsil
Google ilovalari